On the stock market since 2021, it operates in the world of health and science. Now — the numbers.
This is an established company with proven profits.
An average decline of 100% a year over the last 3 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
If every debt were paid off today, $90.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades 23% below its peak. The market has trimmed its expectations for the company.
There is $96.6M in the vault; even if every debt were paid off, $90.6M would remain.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
The sales tempo runs behind the sector. Council score: 2/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
On our five-subject report card, BCYPU sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: BCYPU is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.